ADMA Biologics, Inc.
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey. Show More...
-
Website https://www.admabiologics.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 19.84 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-06 2011-06 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -0.010 -0.010 -1.57 -2.38 -1.81 -1.73 -1.61 -1.91 -1.45 -0.89 -0.87 Dividends USD Payout Ratio % * Shares Mil 3.0 3.0 5.0 7.0 9.0 10.0 12.0 23.0 45.0 54.0 61.0 Book Value Per Share * USD -0.08 0.99 0.46 -0.010 0.29 0.8 0.61 1.12 Free Cash Flow Per Share * USD -1.08 -1.78 -1.46 -1.63 -1.66 -1.42 -1.53 Return on Assets % -170.88 -257.84 -93.83 -65.33 -56.79 -70.55 -82.34 -66.45 -66.78 -44.71 -37.73 Financial Leverage (Average) 1.65 1.48 4.53 28.89 2.68 4.5 4.85 2.19 Return on Equity % -154.91 -100.19 -121.91 -526.23 -243.95 -218.77 -210.08 -102.39 Return on Invested Capital % -83.99 -74.51 -65.43 -86.14 -87.18 -82.02 -45.83 -34.51 Interest Coverage -257.09 -24.12 -12.5 -8.75 -7.71 -12.32 -10.9 -4.37 -4.35 Current Ratio 0.97 0.86 7.68 8.49 5.74 5.05 1.93 6.69 4.63 6.12 11.9 Quick Ratio 0.97 0.86 6.92 7.95 5.3 4.21 1.45 4.98 2.51 2.15 7.79 Debt/Equity 0.42 0.23 2.49 19.14 1.07 2.24 3.23 1.02